FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis

Inflammation Research

Volumn 50, Issue 10, 2001, Pages 509-514

  Sakuma, S ^a   Nishigaki, F ^a   Magari, K ^a   Ogawa, T ^a   Miyata, S ^a   Ohkubo, Y ^a   Goto, T ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Adjuvant induce arthritis; FK506; Grip strength; Hyperalgesia; Methotrexate

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE; PLACEBO; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; GRIP STRENGTH; HISTOPATHOLOGY; HUMAN; HYPERALGESIA; IMMUNOTOXICITY; LEUKOCYTE COUNT; MYCOBACTERIUM TUBERCULOSIS; NEUROTOXICITY; NONHUMAN; PAW EDEMA; PERIPHERAL CIRCULATION; RAT; THYMUS;

EID: 0034783662     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000227     Document Type: Article

References (35)

1. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis
2. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis
3. Biologic agents for treating rheumatoid arthritis. Concepts and progress
4. Anticytokine therapy in rheumatoid arthritis
5. FK506, a novel immunosuppressant isolated from streptomyces. II. Immunosuppressive effect of FK506 in vitro
6. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation
7. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes
8. Efficacy of FK506 in rheumatoid arthritis (RA): A 6 month, dose-ranging study in RA patients failing methotrexate (MTX)
9. FK506 potently inhibits T cell activation induced TNF-α and IL-1β production in vitro by human peripheral blood mononuclear cells
10. Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis: An update on mechanisms of action
11. Molecular therapeutics. Methotrexate and its mechanism of action
12. Antifolates in rheumatoid arthritis: A hypothetical mechanism of action
13. Models of arthritis and the search for anti-arthritic drugs
14. A new spin on an old model. In vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat
15. Studies on the effect of low dose methotrexate on rat adjuvant arthritis
16. The effect of immunomodulating drugs on adjuvant-induced arthritis in Lewis rats
17. Short term low dose methotrexate ameliorates abnormal bone metabolism and bone loss in adjuvant induced arthritis
18. The oral dosage form of FK-506
19. A method for measurement of analgesic activity on inflamed tissue
20. A new animal model for assessing mechanisms and management of muscle hyperalgesia
21. Antiarthritic activities of orally administered FK-506, rapamycin, and combinational therapy in rat established adjuvant arthritis
22. The mechanism of action of cyclosporin A and FK506
23. FK506 attenuates developing and established joint inflammation and suppresses interleukin 6 and nitric oxide expression in bacterial cell wall induced polyarthritis
24. Elevated levels of TNF in the joints of adjuvant arthritic rats
25. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis
26. Effect of methotrexate on murine bone marrow cells in vitro: Evidence of a reversible antiproliferative action
27. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: A metabolic basis for efficacy in rheumatoid arthritis?
28. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation
29. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides
30. Methotrexate specifically modulate cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): A mechanism for methotrexate-mediated immunosuppression
31. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: Inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process
32. Functional assessment of the hand: Reproducibility, acceptability, and utility of a new system for measuring strength
33. Relationship between weakness and muscle wasting in rheumatoid arthritis
34. A comparison of clinical assessments of disease activity in rheumatoid arthritis
35. Use of the rotarod in determining grip strength in rats with adjuvant-induced arthritis